Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

frrol,

Thanks for the post. I brought up CPM(critical path scheduling(method) in the past). Doesn't sound as though he's familiar with it.

https://hbr.org/1963/09/the-abcs-of-the-critical-path-method

1. LE 6/15/18 response:We expect to update shareholders shortly. The anticipated sequence of news will be a) Data Lock, and b) thereafter, top-line results.
LE 1/16/18 pr:"... In coming weeks, we look forward to advancing these discussions with attractive partnership / licensing scenarios, towards determining the best path forward for the Company and its loyal shareholders.” Shortly?

2.LE 6/15/18: We sold stock at a fixed price. Albeit low but we needed funds for production of Brilacidin for further studies and other clinical trial payables. Hope the other payables do not include "the Ehrlich loan".

3.Please anticipate our update as all this is being worked on.

The anticipation.

4. The trial will be unblinded shortly. It's a function of company resources allocated to each product.

Brings us back to Q1 (full circle)

Thanks again for posting, and am grateful to the company for responding. Just wish they could be more definitive or specific.